Biosensors are established as promising analytical tools for detecting various analytes important in biomedicine and environmental monitoring. Using fiber optic technology as a sensing element in biosensors offers low cost, high sensitivity, chemical inertness, and immunity to electromagnetic interference. Optical fiber sensors can be used in in vivo applications and multiplexed to detect several targets simultaneously. Certain configurations of optical fiber technology allow the detection of analytes in a label-free manner. This review aims to discuss recent advances in label-free optical fiber biosensors from a technological and application standpoint. First, modern technologies used to build label-free optical fiber-based sensors will be discussed. Then, current applications where these technologies are applied are elucidated. Namely, examples of detecting soluble cancer biomarkers, hormones, viruses, bacteria, and cells are presented.
The detection of soluble proteins in biological fluids, as a form of liquid biopsy, is a promising tool for cancer diagnosis and prognosis, as it is less invasive than traditional diagnostic methods. CD44 is one of the most recognized markers of cancer stem cells, a small subset of cells responsible for cancer initiation, progression, and metastasis. Given the importance of CD44 as a cancer biomarker, several review articles explore the diagnostic and therapeutic value of cell-surface CD44. In addition to being a membrane-anchored protein, CD44 is also shed from the cell surface and can be found in various biological fluids. However, the role of soluble CD44 in cancer has not been comprehensively discussed in recent reviews. Measuring soluble CD44 in various biological liquids can provide a practical and valuable tool for cancer diagnosis and treatment monitoring. Therefore, this review comprehensively discusses the role of soluble CD44 as a marker in various cancer types, including serum, saliva, urine, and other fluids. In particular, its role as an early cancer biomarker and as a predictive and prognostic biomarker in several cancers is discussed. This work also provides an overview of a wide range of analytical techniques used to detect soluble CD44. The value of cells expressing CD44 versus soluble CD44 as a biomarker is also compared. The review concludes with a perspective on future directions, emphasizing the shift toward non-invasive analytical methods and the need for standardization of detection, including multiple biomarkers during evaluation, to improve the accuracy of cancer diagnosis.
In this letter, we report a tilted fiber Bragg grating (TFBG) with a laser-induced graphene coating. The device displays a cladding mode pattern with a bandwidth of 44 nm. Each spectral dip and peak senses the refractive index change, with sensitivities up to 9.62 dB/refractive index units (RIUs) and 4.00 dB/RIU, respectively. The interrogation of the whole spectral feature envelope can be performed either in the wavelength or in the amplitude domain, with sensitivities of 11.21 nm/RIU and 7.15 dB/RIU, respectively. The graphene-coated TFBG provides improved sensitivity over a standard TFBG with a simple fabrication process and does not require additional components (such as polarizers or intensity-modulating devices) or fiber manipulations (such as etching, tapering, or capillaries). The achieved precision of up to 4.17 × 10-4 RIU is compatible with refractometry and biosensing applications.
A semi-distributed interferometer is a low-reflectivity device with refractive index sensing capability, exploiting the random reflectivity of a nanoparticle-doped fiber to form a weak distributed cavity. In this work, we extend this concept to an extrinsic semi-distributed interferometer (ESDI), using an overlay made of polydimethylsiloxane (PDMS) around the fiber tip; this structure can then be surface-modified using a thin metallic film or a nanoparticle coating. We report gold-sputtered and gold-nanoparticle-coated ESDI structures for refractive index sensing capability, with the latter achieving superior performances with an average sensitivity of 62.8 dB/RIU (refractive index units) with resolution of 3.9 × 10−5 RIU over the range of 1.34790–1.35981. We also report a possible biological application using a biofunctionalized version of this probe for the detection of VEGF (vascular endothelial growth factor); the gold-sputtered probe achieves the highest sensitivity, 0.0565 dB for each 10× concentration increase, with 355 fM detection limit.